Total Payments
$1,580
2024 Payments
$158.94
Companies
16
Transactions
84
Medicare Patients
1,636
Medicare Billing
$392,603
Payment Breakdown by Category
Food & Beverage$1,580 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,580 | 84 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $605.91 | 39 | $0 (2024) |
| ITI, Inc. | $222.38 | 10 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $141.65 | 2 | $0 (2017) |
| Alkermes, Inc. | $91.47 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $79.69 | 3 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $64.34 | 7 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $61.09 | 2 | $0 (2024) |
| Allergan, Inc. | $56.92 | 3 | $0 (2020) |
| Amarin Pharma Inc. | $55.65 | 3 | $0 (2021) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $52.48 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $158.94 | 7 | Vanda Pharmaceuticals Inc. ($61.09) |
| 2023 | $202.97 | 15 | AbbVie Inc. ($159.57) |
| 2022 | $371.17 | 21 | ITI, Inc. ($201.79) |
| 2021 | $360.14 | 18 | AbbVie Inc. ($257.68) |
| 2020 | $71.38 | 4 | Allergan, Inc. ($21.94) |
| 2019 | $99.68 | 4 | Janssen Pharmaceuticals, Inc ($79.69) |
| 2018 | $24.09 | 2 | Sunovion Pharmaceuticals Inc. ($24.09) |
| 2017 | $291.78 | 13 | Otsuka America Pharmaceutical, Inc. ($141.65) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $35.36 | General |
| Category: SCHIZOPHRENIA | ||||||
| 08/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: PSYCHIATRY | ||||||
| 07/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: SCHIZOPHRENIA | ||||||
| 06/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: PSYCHIATRY | ||||||
| 05/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/13/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/15/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: CNS | ||||||
| 07/21/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: PSYCHIATRY | ||||||
| 02/03/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2022 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA INITIO | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: CNS | ||||||
| 10/14/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 433 | 1,415 | $264,641 | $108,518 |
| 2022 | 5 | 337 | 1,252 | $227,918 | $99,888 |
| 2021 | 6 | 332 | 1,068 | $184,958 | $85,531 |
| 2020 | 9 | 534 | 1,527 | $236,728 | $98,666 |
Total Patients
1,636
Total Services
5,262
Medicare Billing
$392,603
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 214 | 720 | $135,801 | $53,780 | 39.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 145 | 520 | $105,556 | $42,784 | 40.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 33 | 134 | $13,400 | $7,853 | 58.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 41 | 41 | $9,884 | $4,101 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 231 | 1,047 | $196,811 | $84,072 | 42.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 33 | 119 | $11,900 | $7,305 | 61.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 29 | 37 | $7,565 | $3,176 | 42.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $6,392 | $2,903 | 45.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 21 | $5,250 | $2,431 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 179 | 728 | $139,969 | $60,862 | 43.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 76 | 211 | $24,661 | $14,811 | 60.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 22 | 54 | $5,400 | $3,301 | 61.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 23 | 28 | $7,587 | $3,019 | 39.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 19 | 19 | $4,391 | $2,035 | 46.3% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 28 | $2,950 | $1,504 | 51.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 266 | 887 | $143,949 | $53,706 | 37.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 124 | 431 | $59,332 | $30,722 | 51.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 22 | 44 | $8,707 | $4,560 | 52.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 37 | 37 | $8,790 | $3,554 | 40.4% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 23 | 53 | $5,213 | $3,376 | 64.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 19 | 27 | $5,400 | $1,109 | 20.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 17 | $1,700 | $747.55 | 44.0% |
| 90838 | Psychotherapy, 60 minutes | Office | 2020 | 13 | 13 | $937.69 | $671.77 | 71.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 18 | 18 | $2,700 | $219.42 | 8.1% |
About Dr. Gary Weinstein, MD
Dr. Gary Weinstein, MD is a Psychiatry healthcare provider based in Forest Hills, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184712945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Weinstein, MD has received a total of $1,580 in payments from pharmaceutical and medical device companies, with $158.94 received in 2024. These payments were reported across 84 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,580).
As a Medicare-enrolled provider, Weinstein has provided services to 1,636 Medicare beneficiaries, totaling 5,262 services with total Medicare billing of $392,603. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Forest Hills, NY
- Active Since 10/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1184712945
Products in Payments
- VRAYLAR (Drug) $620.22
- CAPLYTA (Drug) $274.86
- REXULTI (Drug) $141.65
- INVOKANA (Drug) $79.69
- ARISTADA (Drug) $68.66
- LATUDA (Drug) $64.34
- FANAPT (Drug) $61.09
- Vascepa (Drug) $55.65
- VYVANSE (Drug) $44.04
- UBRELVY (Drug) $26.68
- LYBALVI (Drug) $22.81
- NUEDEXTA (Drug) $22.29
- Nuedexta (Drug) $20.73
- AFREZZA (Drug) $16.77
- XIFAXAN (Drug) $16.37
- CREON (Drug) $15.93
- SUBOXONE SUBLINGUAL FILM (Drug) $14.49
- Aimovig (Biological) $13.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Forest Hills
Isak Isakov
Psychiatry — Payments: $550,068
Psychiatry $550,068
Leonid Izrayelit, Md, MD
Psychiatry — Payments: $6,400
Psychiatry $6,400
Yu Yang, M.d, M.D
Psychiatry — Payments: $4,416
Psychiatry $4,416
Shama Rasool, Md, MD
Psychiatry — Payments: $2,008
Psychiatry $2,008
Dr. Lober Cervantes, Md, MD
Psychiatry — Payments: $1,167
Psychiatry $1,167
Dr. Ebby Ohebshalom, M.d, M.D
Psychiatry — Payments: $890.78
Psychiatry $890.78